The health and financial benefits for households from averting malaria with RTS,S/AS01 vaccine in Zambia: an extended cost-effectiveness analysis

Malaria remains one of the leading causes of mortality for children under five years old in many sub-Saharan African countries. We examined the household health and financial benefits associated with the hypothetical rollout of the malaria vaccine RTS,S/AS01 in Zambia.